Patient Preferences and Urologist Judgments on Prostate Cancer Therapy in Japan

American Journal of Men's Health
Masahiko NakayamaJörg Mahlich

Abstract

The purpose of the present study is to investigate the concordance of treatment preferences between patients and physicians in prostate cancer (PCa) in Japan. An internet-based discrete choice experiment was conducted. Patients and physicians were asked to select their preferred treatment from a pair of hypothetical treatments consisting of four attributes: quality of life (QOL), treatment effectiveness, side effects, and accessibility of treatment. The data were analyzed using a conditional logistic regression model to calculate coefficients and the relative importance (RI) of each attribute. A total of 103 PCa patients and 127 physicians responded. The study looked at 37 patients considered as advanced PCa and 66 who were non-advanced PCa. All of the physicians were urologists. Advanced PCa patients ranked the attributes as follows: treatment effectiveness (RI: 32%), accessibility of treatment (RI: 26%), QOL (RI: 23%), and side effects (RI: 19%). For physicians, the RI ranking was the same as for advanced PCa patients; treatment effectiveness (RI: 29%), accessibility of treatment (RI: 27%), QOL (RI: 26%), and side effects (RI: 18%). For non-advanced PCa patients, accessibility of treatment ranked the highest RI (27%) and trea...Continue Reading

References

Jun 2, 2000·BMJ : British Medical Journal·M Ryan, S Farrar
Jan 31, 2004·BMJ : British Medical Journal·Mark SculpherMark Emberton
Jul 31, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Nancy K JanzEdwin G Wilkins
Oct 8, 2004·The New England Journal of Medicine·Ian F TannockUNKNOWN TAX 327 Investigators
Jun 27, 2007·Journal of Palliative Medicine·Susan DesHarnaisCindy Carter
Jul 20, 2007·Prostate Cancer and Prostatic Diseases·A LloydL Kleinman
Apr 23, 2008·Archives of Surgery·James D HarrisonStephen Clarke
Apr 23, 2008·Prostate Cancer and Prostatic Diseases·P C StoneM Q Almerie
Jul 16, 2008·PharmacoEconomics·Emily Lancsar, Jordan Louviere
Nov 7, 2008·Cancer·Neal J MeropolUNKNOWN CONNECT Study Research Group
Apr 23, 2009·International Journal of Urology : Official Journal of the Japanese Urological Association·Tetsuya FujimuraYukio Homma
Aug 18, 2009·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·L van DamM E van Leerdam
Jun 29, 2010·International Journal of Clinical Practice·M Emberton
Sep 8, 2010·The New England Journal of Medicine·Philip W KantoffUNKNOWN IMPACT Study Investigators
May 27, 2011·The New England Journal of Medicine·Johann S de BonoUNKNOWN COU-AA-301 Investigators
Aug 17, 2012·The New England Journal of Medicine·Howard I ScherUNKNOWN AFFIRM Investigators
Mar 27, 2013·Applied Health Economics and Health Policy·Axel C Mühlbacher, Christin Juhnke
May 15, 2013·Health Economics Review·Axel C MühlbacherMatthias Nübling
Nov 11, 2014·Health Expectations : an International Journal of Public Participation in Health Care and Health Policy·Kirsten HowardMichael P Pignone
Jun 19, 2015·Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada·Fred SaadNeil E Fleshner
Jul 17, 2015·JAMA Oncology·UNKNOWN Global Burden of Disease Cancer CollaborationMohsen Naghavi
Jul 25, 2015·Annals of Oncology : Official Journal of the European Society for Medical Oncology·C ParkerUNKNOWN ESMO Guidelines Committee
Aug 12, 2016·Medical Decision Making : an International Journal of the Society for Medical Decision Making·Karen A ScherrPeter A Ubel

❮ Previous
Next ❯

Citations

Aug 14, 2018·Current Opinion in Urology·Takumi Shiraishi, Osamu Ukimura
May 6, 2021·The Patient·Hannah CollacottSebastian Heidenreich

❮ Previous
Next ❯

Methods Mentioned

BETA
pharmacotherapy

Software Mentioned

JMP

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.